• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now

by Fred Pennic 04/29/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now
Photo Credit: Freepik

What You Should Know: 

– Recent changes to U.S. trade policy under the Trump Administration, including a new baseline tariff on imports, are sending ripples through the healthcare industry, creating significant uncertainty and cost pressures. 

– According to recent  analysis by Premier Inc., while a temporary pause on reciprocal tariffs (excluding China) is in effect until early July, the new landscape presents immediate challenges. 

Trump Administration Tariffs Create Cost Uncertainty for Healthcare Supply Chains

Here are five key ways these tariffs are impacting healthcare providers and supply chains right now:

1. Increased Cost Uncertainty Across the Board

The implementation of a baseline 10 percent tariff on all imported goods worldwide (effective April 5, 2025) introduces a new layer of cost unpredictability. This, combined with the rollback of de minimis exemptions for low-value shipments, adds pressure across various categories, including essential medical supplies, devices, pharmaceuticals, foodservice items, and even capital projects for facility upgrades. A January survey cited by Premier found 82 percent of healthcare experts expected tariff-related import expenses to drive up hospital costs by 15 percent within six months, highlighting widespread concern even before the latest policy changes took full effect. The current 90-day pause on reciprocal tariffs, while intended for negotiation, prolongs this period of volatility for healthcare organizations already struggling with inflation and thin margins.

2. Heightened Risk for Imported Medical Devices

The U.S. healthcare system relies heavily on global manufacturing for medical devices. Premier notes that approximately 75 percent of devices marketed in the U.S. are produced outside the country, and a staggering 69 percent are manufactured exclusively abroad. The new baseline tariffs directly impact these imported goods, potentially leading to increased prices and raising concerns about the continued availability of essential devices critical for patient care.

3. Steep Tariffs Hitting Specific Critical Supplies (Especially from China)

While the baseline tariff is 10 percent, goods from China face specific, much higher rates – up to 245 percent. This is particularly concerning given China’s significant role in manufacturing certain healthcare products. Premier provides a stark example: enteral feeding syringes, which currently have no known large-scale manufacturing outside of China, are subject to a potential 245 percent tariff, posing a direct threat to affordability and access for vulnerable patient populations relying on these essential supplies.

4. Looming Threat of New Pharmaceutical Tariffs

Pharmaceuticals, which had largely been exempt from earlier tariff rounds, are now squarely in the crosshairs. President Trump announced in early April that “major tariffs” on imported pharmaceuticals would be introduced soon. Given the global nature of drug manufacturing, including the sourcing of active pharmaceutical ingredients (APIs) often from countries like China, new tariffs in this sector could significantly drive up medication costs for health systems and patients alike, adding another layer of financial strain.

5. Amplified Supply Chain Volatility and Reliance Risks

The complex global network that supports healthcare operations faces increased volatility due to these trade policy shifts. Escalated trade tensions, particularly with China, create risks beyond just cost, potentially impacting the availability of necessary medical devices, drug ingredients, and technological components manufactured there. Because ex-U.S. manufacturing is a critical reality for healthcare sourcing, navigating these tensions and the overall uncertainty introduced by the tariff policies becomes a major strategic challenge for maintaining resilient supply chains.

What Healthcare Leaders Can Do

Premier advises healthcare organizations to take proactive steps now to mitigate these impacts:

  • Demand Supplier Transparency: Obtain detailed data on manufacturing country of origin and risk exposure.
  • Identify Vulnerabilities: Analyze contracts for tariff protections and map organizational risks.
  • Explore GPO Alternatives: Consider transitioning non-protected contracts to GPO agreements for potential price insulation.

(Note: Information reflects the situation as reported by Premier, current as of April 29, 2025. Trade policies remain dynamic.)

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |